Qing Zhou

33PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 26, 2026
FUS inactivation promotes leptomeningeal metastasis of lung cancer through the up-regulation of CD36.

|Jul 10, 2026
The effects of probiotics duration and type on immunotherapy efficacy in non-small cell lung cancer with or without antibiotics.

|Jun 08, 2026
Practice-Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025.

|May 14, 2026
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer.

|Feb 25, 2026
SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer.

Qing Zhou, Bo Gao, Jie Hu

|Nov 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases.

Yang-Si Li, Wenpu Lai, Kai Yin

Pageof 6

Frequent Collaborators

14 joint publications

Yi-Long Wu

8 joint publications

Xu-Chao Zhang

7 joint publications

Siyang Maggie Liu

6 joint publications

Jia-Tao Zhang